| Released | Contributor | Author | Title | Pages | Price |
| 18-Dec-2009 | New Constructs, LLC |
N/A
| SMA: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 |
$10 |
| 18-Dec-2009 | Pechala's Reports | Lubomir Pechala | SYMMETRY MEDICAL INC (SMA=US) - REPORT FOR ACTIVE TRADERS | 4 |
$25 |
| 17-Dec-2009 | Jefferson Research |
N/A
| Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of SYMMETRY MEDICAL INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. | 3 |
$20 |
| 17-Dec-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Health Care Industry Market Research and Competitive Analysis 2010 | 730 |
$299 |
| 17-Dec-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Health Care Industry Trends, Statistics & Analysis 2010 (Summary) | 98 |
$199 |
| 17-Dec-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Plunkett's Health Care Technologies Overview 2010 (Summary) | 80 |
$199 |
| 15-Dec-2009 | EconomicInvestor |
N/A
| "The Economy Matters" Report for SMA: the economy's impact on SMA's price and risk, featuring the powerful EconomicInvestor Star Rating | 6 |
$15 |
| 14-Dec-2009 | Reuters Investment Profile |
N/A
| Symmetry Medical Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
| 14-Dec-2009 | Wright Reports |
N/A
| Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) | 103 |
$169 |
| 14-Dec-2009 | Wright Reports |
N/A
| Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) | 100 |
$169 |
0.20% Nasdaq 
Research Reports
